Method of inhibiting clostridium difficile by administration of oritavancin

Details for Australian Patent Application No. 2008298987 (hide)

International Classifications

Event Publications

1 April 2010 PCT application entered the National Phase

PCT publication WO2009/036121 Priority application(s): WO2009/036121

31 March 2011 Assignment before Grant

UNIVERSITY OF LEEDS; Targanta Therapeutics Corp. The application has been assigned to Targanta Therapeutics Corp.; The Medicines Company

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.